Sharpening the Focus: Identifying Treatment Strategies for Diabetic Retinopathy

Sharpening the Focus: Identifying Treatment Strategies for Diabetic Retinopathy

Sharpening the Focus: Identifying Treatment Strategies for Diabetic Retinopathy
RestartResume

Stay current on the latest advances in diabetic retinopathy and learn how to customize therapy to achieve the best vision outcomes for your patients.

Available credits: 0.25

Time to complete: 15 minutes

Released:

Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    A main goal in the treatment of diabetic retinopathy is to intervene early enough to prevent vision loss. New data are giving us new tools for our armamentarium and helping us define what constitutes “early”—and if there’s such a thing as “too early.” Join us to take a closer look at the data surrounding the management of NPDR and CI-DME with good vision and hear our panelist of experts explain how the data translate into clinical care.

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Host:
    Adrienne Scott, MD
    Associate Professor of Ophthalmology
    Wilmer Eye Institute
    Johns Hopkins University
    Baltimore, MD

    Consulting Fees: Allergan, Inc., Genentech/Roche, Novartis

    Faculty:
    Rajendra Apte, MD, PhD
    Paul A. Cibis Distinguished Professor of Ophthalmology and Visual Sciences
    Washington University in St Louis
    School of Medicine
    St. Louis, MO

    Consulting Fees: Casma, Roche
    Ownership Interest: EdenRoc, Liberty Biosecurity, Iveric, Metro, Q BioMed

    Jennifer I. Lim, MD, FARVO
    Marion H. Schenk Esq. Chair and Professor of Ophthalmology
    Director of Retina Service
    University of Illinois at Chicago
    Chicago, IL

    Contracted Research: Aldeyra Therapeutics, Chengdu Pharmaceuticals, Clearside Biomedical, Genentech, Graybug Vision, Janssen Pharmaceutical, Regeneron Pharmaceuticals, Stealth BioTherapeutics
    Consulting Fees: Alcon, Allergan, Aura Biosciences, Cognition Therapeutics, Eyenuk, EyePoint Pharmaceuticals, Iveric bio, Kodiak Sciences, Novartis, Ophthea, Quark Pharmaceuticals, Santen Pharmaceutical

    Reviewers/Content Planners/Authors:

    • Emily Chew, MD, has nothing to disclose.
    • Cindy Davidson has nothing to disclose.
    • Ann Early has nothing to disclose.
    • Amanda Hilferty has nothing to disclose.
    • Robert Schneider, MSW, has nothing to disclose.
    • Stephanie Wenick, MPhil, has nothing to disclose.
  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Evaluate emerging evidence illustrating the need for a preventive approach to the treatment of nonproliferative diabetic retinopathy
    • Apply evidence-based treatment strategies that best prevent progression of diabetic retinopathy and its vision-threatening complications
  • Target Audience

    This activity is designed to meet the educational needs of retina specialists, ophthalmologists, eye health nurses, primary care physicians, nurse practitioners, physician assistants, and nurses.

  • Accreditation and Credit Designation Statements

    In support of improving patient care, Global Learning Collaborative (GLC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

    Global Learning Collaborative (GLC) designates this enduring activity for a maximum of .25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Global Learning Collaborative (GLC) designates this activity for 15 minutes of nursing contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider(s)/Educational Partner(s)

    Prova Education designs and executes continuing education founded on evidence-based medicine, clinical need, gap analysis, learner feedback, and more. Our mission is to serve as an inventive and relevant resource for clinical content and educational interventions across a broad spectrum of specialties. 

    Prova Education's methodology demonstrates a commitment to continuing medical education and the innovative assessment of its effects. Our goal is clear—to develop and deliver the very best education in the most impactful manner and to verify its results with progressive outcomes research.  

    This activity is provided in partnership with the National Eye Institute, of the National Institutes of Health, of the US Department of Health and Human Services. The National Eye Health Education Program of the NEI is acknowledged for its important contributions to this initiative.

  • Commercial Support

    This activity is supported by an independent educational grant from Regeneron Pharmaceuticals Inc.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Prova Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Prova Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited
    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.

Facebook Comments

Register

We’re glad to see you’re enjoying Eye Health Academy…
but how about a more personalized experience?

Register for free